Catalyst Wire Dossier Catalyst Wire Dossier

Rituximab BS

rituximab · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rituximab BS, covering 2025-05-31 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

See pricing